Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New concepts in Parkinson's disease.

P J Sweeney1

  • 1Neurology Residency Program, Cleveland Clinic Foundation.

Hospital Practice (Office Ed.)
|April 15, 1991
PubMed
Summary

New therapies target environmental toxins causing dopaminergic neuron death. Treatments aim to slow cell death and restore dopamine synthesis through drugs or cell implantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pronase (EC 3.4.24.4).

Methods in molecular biology (Clifton, N.J.)·2008
Same author

Proteolytic enzymes for peptide production.

Methods in molecular biology (Clifton, N.J.)·2008
Same author

Proteinase K (EC 3.4.21.14).

Methods in molecular biology (Clifton, N.J.)·2008
Same author

Aminopeptidases: aminopeptidase M (EC 3.4.11.2), pyroglutamate aminopeptidase (EC 3.4.19.3), and prolidase (EC 3.4.13.9).

Methods in molecular biology (Clifton, N.J.)·2008
Same author

A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors.

Neurology·2003
Same author

Metastatic adenocarcinoma to a pituitary adenoma.

Annals of diagnostic pathology·2001

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Research highlights environmental factors detrimental to dopaminergic neurons in the substantia nigra.
  • Understanding these toxins is crucial for developing effective Parkinson's disease therapies.

Purpose of the Study:

  • To review emerging therapies for conditions involving dopaminergic neuron degeneration.
  • To discuss novel pharmacological and surgical approaches for neuroprotection and dopamine restoration.

Main Methods:

  • Literature review of recent advancements in neurodegenerative disease research.
  • Analysis of preclinical and clinical data on new therapeutic strategies.

Main Results:

  • Identification of drug candidates that may slow the progression of nigral cell death.
  • Evaluation of surgical interventions, including fetal and genetically engineered cell transplantation, for dopamine restoration.

Conclusions:

  • Emerging therapies show promise in slowing neurodegeneration and restoring function.
  • Further research is needed to validate the efficacy and safety of these novel treatments.

Related Experiment Videos